Surabhi Imaging & Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.35 Cr
as on 05-12-2024
- Paid Up Capital ₹ 4.26 Cr
as on 05-12-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 3.21 Cr
as on 05-12-2024
- Revenue 1410.69%
(FY 2020)
- Profit 87.56%
(FY 2020)
- Ebitda 759.00%
(FY 2020)
- Net Worth 320.59%
(FY 2020)
- Total Assets 48.62%
(FY 2020)
About Surabhi Imaging & Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 4.35 Cr and a paid-up capital of Rs 4.26 Cr.
The company currently has active open charges totaling ₹3.21 Cr.
Manjula Maddila, Srilakshmi Rachaputi, Ambatipudi Venkata, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100AP2014PTC094984
- Company No.
094984
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2014
- Date of AGM
30 Jan 2022
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Surabhi Imaging & Medical Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manjula Maddila  | Director | 04-Aug-2014 | Current |
| Srilakshmi Rachaputi | Additional Director | 05-Jul-2019 | Current |
Ambatipudi Venkata  | Additional Director | 13-Dec-2016 | Current |
| Maddila Sridhar | Director | 05-Jul-2019 | Current |
Financial Performance of Surabhi Imaging & Medical Sciences.
Surabhi Imaging & Medical Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1410.69% increase. The company also saw a substantial improvement in profitability, with a 87.56% increase in profit. The company's net worth Soared by an impressive increase of 320.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surabhi Imaging & Medical Sciences?
In 2020, Surabhi Imaging & Medical Sciences had a promoter holding of 54.31% and a public holding of 45.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Nov 2020 | ₹1.91 Cr | Open |
Others Creation Date: 14 Oct 2016 | ₹7.00 M | Open |
Reliance Capital Ltd Creation Date: 23 Mar 2015 | ₹6.00 M | Open |
How Many Employees Work at Surabhi Imaging & Medical Sciences?
Unlock and access historical data on people associated with Surabhi Imaging & Medical Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surabhi Imaging & Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surabhi Imaging & Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
